Trial Details

NOT_YET_RECRUITING
Basic Information
Clinical ID c797
Identifier NCT06625450
Trial Title TOFACITINIB vs TOFACITINIB WITH MESALAMINE IN ULCERATIVE COLITIS
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: Tofacitinib|DRUG: Tofacitinib plus mesalamine
Participant Information
Sponsor Post Graduate Institute of Medical Education and Research, Chandigarh
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2025-10-24
Primary Completion Date 2025-12-25
Completion Date 2025-01-26